Intratumoral lymphocyte density in serous ovarian carcinoma is superior to ERCC1 expression for predicting response to platinum-based therapy
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Intratumoral lymphocyte density in serous ovarian carcinoma is superior to ERCC1 expression for predicting response to platinum-based therapy
Authors
Keywords
-
Journal
VIRCHOWS ARCHIV
Volume 459, Issue 2, Pages 183-191
Publisher
Springer Nature
Online
2011-06-30
DOI
10.1007/s00428-011-1110-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Single nucleotide polypmorphisms in ERCC1 are associated with disease progression, and survival in patients with advanced stage ovarian and primary peritoneal carcinoma; A Gynecologic Oncology Group Study
- (2011) Thomas C. Krivak et al. GYNECOLOGIC ONCOLOGY
- Excision repair cross-complementation group 1 protein overexpression as a predictor of poor survival for high-grade serous ovarian adenocarcinoma
- (2010) Stefanie Scheil-Bertram et al. GYNECOLOGIC ONCOLOGY
- Profound elevation of CD8+ T cells expressing the intraepithelial lymphocyte marker CD103 (αE/β7 Integrin) in high-grade serous ovarian cancer
- (2010) John R. Webb et al. GYNECOLOGIC ONCOLOGY
- The Relationship of Platinum Resistance and ERCC1 Protein Expression in Epithelial Ovarian Cancer
- (2010) Karina Dahl Steffensen et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Intraepithelial CD8-positive T lymphocytes predict survival for patients with serous stage III ovarian carcinomas: relevance of clonal selection of T lymphocytes
- (2009) M Stumpf et al. BRITISH JOURNAL OF CANCER
- Intraepithelial T cells and tumor proliferation
- (2009) Sarah F. Adams et al. CANCER
- Immunodetection of DNA Repair Endonuclease ERCC1-XPF in Human Tissue
- (2009) N. R. Bhagwat et al. CANCER RESEARCH
- Ovarian cancer tumor infiltrating T-regulatory (Treg) cells are associated with a metastatic phenotype
- (2009) Jason C. Barnett et al. GYNECOLOGIC ONCOLOGY
- Expression of excision repair cross-complementation group 1 protein predicts poor outcome in advanced non-small cell lung cancer patients treated with platinum-based doublet chemotherapy
- (2009) Hyun Woo Lee et al. LUNG CANCER
- T Cell Density and Location Can Influence the Prognosis of Ovarian Cancer
- (2009) Ahmad Al-Attar et al. PATHOLOGY & ONCOLOGY RESEARCH
- Systematic Analysis of Immune Infiltrates in High-Grade Serous Ovarian Cancer Reveals CD20, FoxP3 and TIA-1 as Positive Prognostic Factors
- (2009) Katy Milne et al. PLoS One
- The DNA repair proteins BRCA1 and ERCC1 as predictive markers in sporadic ovarian cancer
- (2008) Johanne Weberpals et al. INTERNATIONAL JOURNAL OF CANCER
- Sporadic Epithelial Ovarian Cancer: Clinical Relevance of BRCA1 Inhibition in the DNA Damage and Repair Pathway
- (2008) Johanne I. Weberpals et al. JOURNAL OF CLINICAL ONCOLOGY
- Relationship BetweenERCC1Polymorphisms, Disease Progression, and Survival in the Gynecologic Oncology Group Phase III Trial of Intraperitoneal Versus Intravenous Cisplatin and Paclitaxel for Stage III Epithelial Ovarian Cancer
- (2008) Thomas C. Krivak et al. JOURNAL OF CLINICAL ONCOLOGY
- Excision repair cross-complementation group 1 (ERCC1) in platinum-based treatment of non-small cell lung cancer with special emphasis on carboplatin: A review of current literature
- (2008) Adam Vilmar et al. LUNG CANCER
- Intraepithelial T cells and prognosis in ovarian carcinoma: novel associations with stage, tumor type and BRCA1 loss
- (2008) Blaise Clarke et al. MODERN PATHOLOGY
- Prognostic significance of CD3+ tumor-infiltrating lymphocytes in ovarian carcinoma
- (2007) Markéta Tomšová et al. GYNECOLOGIC ONCOLOGY
- Prediction of response to chemotherapy by ERCC1 immunohistochemistry and ERCC1 polymorphism in ovarian cancer
- (2007) K.D. STEFFENSEN et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now